None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Type 2 diabetic patients categorized as well controlled. HbA1C less than 7.5. (American Diabetes Association Guidelines 2017) 2.No active intraoral or systemic disease. 3.Mandibular bilaterally edentulous posterior teeth with satisfactory healing after tooth loss. 4.Minimum height of available bone - 11.5mm in the edentulous site.
Exclusion criteria
Exclusion criteria: 1.Uncontrolled diabetic patients. 2.History of radiation therapy in the head and neck region. 3.Severe clenching or bruxism. 4.Smokers 5.Drug or alcohol abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The sites receiving igf-1 will have increased bone formation when compared to the site receiving placebo microspheres.Timepoint: Osseointegration around dental implants will be assessed at the 90th day after implant placement | — |
Secondary
| Measure | Time frame |
|---|---|
| To check the activity of insulin like growth factor-1 on osseointegration. To assess and compare the bone healing between the control and test at two different time intervals.Timepoint: Osseointegration around dental implants will be assessed at 30th and 60th day after implant placement. | — |
Countries
India
Contacts
sri ramachandra university